Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Third-Generation EGFR Tyrosine Kinase Inhibitor

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e181-e182
Number of pages2
JournalJournal of Thoracic Oncology
Issue number11
Publication statusPublished - Nov 1 2017

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this